Latest Share Chat

REMOVE ADS

Glaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes

Get Live Data

1,913.00 0.00 (0.00%)

Bid:

1,802.00

Ask:

1,999.00

Spread: 197.00 (10.932%)

Market Cap: £76.72b

Last checked at -

Intraday Glaxosmithkline Share Chart

REMOVE ADS

Glaxosmithkline News

LONDON MARKET OPEN: European stocks rise on trade agreement

(Alliance News) - Equities in Europe started the week strongly, after the US and EU agreed a trade deal and on hope that the Donald Trump administrati...

GSK strikes USD12 billion drug portfolio deal with Hengrui Pharma

(Alliance News) - GSK PLC on Monday said it has teamed up with China's Jiangsu Hengrui Pharmaceuticals Co Ltd in a deal worth up to USD12 billion to d...

LONDON BRIEFING: GSK in USD12 billion drug portfolio deal with Hengrui

(Alliance News) - GSK announced a partnership with China's Hengrui, Cranswick said it expects results in line with market expectations, while STV warn...

GSK and Hengrui unveil development deal worth up to $12bn

(Sharecast News) - GSK has entered into a partnership with Chinese pharmaceutical outfit Hengrui Pharma to jointly develop up to 12 medicines, in a de...

GSK hails EU approval for blood cancer drug as US regulator wavers

(Alliance News) - GSK PLC on Thursday said its Blenrep blood cancer treatment has been approved in Europe, as it awaits a final decision from the US r...

GSK's blood cancer drug gets EU approval

July 24 (Reuters) - The European Union has approved GSK's drug Blenrep to treat relapsed or treatment-resistant forms of a cancer affecting blood pl...

GSK's blood cancer drug gets EU approval for multiple myeloma

July 24 (Reuters) - British drugmaker GSK said on Thursday the European Union has approved the company's blood cancer drug Blenrep for the treatment o...

FTSE 100 notches record close on US-EU trade deal optimism, earnings boost

FTSE 100 up 0.9%, FTSE 250 up 0.6% *